Stockscreener 앱 받기
1.70
2.86%
-0.05
시장 영업 전:
1.69
-0.01
-0.59%
전일 마감가:
$1.75
열려 있는:
$1.71
하루 거래량:
744.17K
Relative Volume:
0.35
시가총액:
$74.10M
수익:
$16.77M
순이익/손실:
$-11.87M
주가수익비율:
-3.585
EPS:
-0.4742
순현금흐름:
$-5.90M
1주 성능:
-6.59%
1개월 성능:
+69.15%
6개월 성능:
+163.77%
1년 성능:
+100.00%
1일 변동 폭
$1.61
$1.77
1주일 범위
$1.61
$1.99
52주 변동 폭
$0.30
$2.3173
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
IPA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
1.70 | 83.29M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-12-02 | 개시 | H.C. Wainwright | Buy |
| 2021-10-25 | 개시 | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd 주식(IPA)의 최신 뉴스
What drives ImmunoPrecise Antibodies Ltd. stock priceDynamic portfolio growth - Autocar Professional
What analysts say about ImmunoPrecise Antibodies Ltd. stockFree Predictions - jammulinksnews.com
Is ImmunoPrecise Antibodies Ltd. a good long term investmentExceptional portfolio growth - Autocar Professional
ImmunoPrecise Antibodies Ltd. Stock Analysis and ForecastRapid portfolio appreciation - jammulinksnews.com
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Stock Price Down 0.6% – What’s Next? - Defense World
ImmunoPrecise Strengthens Advisory Board with AI Expert Jeff Fried - TipRanks
ImmunoPrecise Antibodies appoints data expert Jeff Fried to advisory board - Investing.com Australia
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board - Yahoo Finance
Is ImmunoPrecise Antibodies Ltd. stock a good hedge against inflationFree Investment Portfolio Suggestions - beatles.ru
why immunoprecise antibodies ltd. stock attracts strong analyst attentionMarket Beating Strategy - Newser
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025 - 01net
ImmunoPrecise Antibodies to Announce Q4 and FY 2025 Results - TipRanks
Why ImmunoPrecise Antibodies Ltd. stock attracts strong analyst attentionElite Stock Shortlist - Newser
How ImmunoPrecise Antibodies Ltd. stock performs during market volatilityShort Squeeze Radar - Newser
Tech Momentum Surges as IPA, HIT, SNYR, PNPN.V, KAPA and Others Drive Investor Awareness – More Stocks Inside - FinancialContent
What makes ImmunoPrecise Antibodies Ltd. stock price move sharplyFree Risk Assessment Services - Newser
ImmunoPrecise Regains Nasdaq Compliance, Strengthening Market Position - The Globe and Mail
ImmunoPrecise regains Nasdaq compliance as share price stabilizes By Investing.com - Investing.com South Africa
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement - 01net
ImmunoPrecise Antibodies Ltd Inc. (IPA) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com
ImmunoPrecise regains Nasdaq compliance as share price stabilizes - Investing.com
ImmunoPrecise Antibodies Appoints Jon Lieber to Board of Directors - citybiz
ImmunoPrecise Antibodies Strengthens Board with Industry Veteran Jon Lieber - TipRanks
ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors - New Castle News
ImmunoPrecise Antibodies’ LENSai Platform Achieves Breakthrough in Epitope Mapping Accuracy - Insider Monkey
ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data - 01net
ImmunoPrecise Antibodies Skyrockets: AI-Powered Drug Discovery Takes Center Stage - RagingBull
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Down 0.5% – Here’s Why - Defense World
ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology | IPA Stock News - GuruFocus
Even With A 72% Surge, Cautious Investors Are Not Rewarding ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Performance Completely - simplywall.st
Market Recap: ImmunoPrecise Antibodies Ltd (IPA)’s Positive Momentum, Closing at 0.95 - DWinneX
We're Keeping An Eye On ImmunoPrecise Antibodies' (NASDAQ:IPA) Cash Burn Rate - Yahoo Finance
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Sees Large Growth in Short Interest - Defense World
ImmunoPrecise stock rating reiterated at Buy by H.C. Wainwright - Investing.com India
Immunoprecise Antibodies Ltd (IPA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.51%
자본화:
|
볼륨(24시간):